Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine

Cancer Res. 2006 Dec 1;66(23):11494-501. doi: 10.1158/0008-5472.CAN-06-1497.

Abstract

The present study investigated the inhibitory effects of Polyphenon E [a standardized green tea polyphenol preparation containing 65% (-)-epigallocatechin-3-gallate] and caffeine on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumor progression from adenoma to adenocarcinoma. Female A/J mice were treated with a single dose of NNK (103 mg/kg body weight, i.p.) and kept for 20 weeks for the mice to develop lung adenomas. The mice were then given a solution of 0.5% Polyphenon E or 0.044% caffeine as the sole source of drinking fluid until week 52. Both treatments significantly decreased the number of visible lung tumors. Histopathologic analysis indicated that Polyphenon E administration significantly reduced the incidence (by 52%) and multiplicity (by 63%) of lung adenocarcinoma. Caffeine also showed marginal inhibitory effects in incidence and multiplicity of adenocarcinoma (by 48% and 49%, respectively). Markers of cell proliferation, apoptosis, and related cell signaling were studied by immunohistochemistry, and the labeling index and staining intensity were quantified by the Image-Pro system. Polyphenon E and caffeine treatment inhibited cell proliferation (by 57% and 50%, respectively) in adenocarcinomas, enhanced apoptosis in adenocarcinomas (by 2.6- and 4-fold, respectively) and adenomas (both by 2.5-fold), and lowered levels of c-Jun and extracellular signal-regulated kinase (Erk) 1/2 phosphorylation. In the normal lung tissues, neither agent had a significant effect on cell proliferation or apoptosis. The results show that tea polyphenols (and perhaps caffeine) inhibit the progression of NNK-induced lung adenoma to adenocarcinoma. This effect is closely associated with decreased cell proliferation, enhanced apoptosis, and lowered levels of c-Jun and Erk1/2 phosphorylation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenocarcinoma / metabolism
  • Adenocarcinoma / pathology
  • Adenocarcinoma / prevention & control*
  • Adenoma / chemically induced
  • Adenoma / pathology
  • Adenoma / prevention & control*
  • Analysis of Variance
  • Animals
  • Caffeine / administration & dosage
  • Caffeine / therapeutic use*
  • Catechin / administration & dosage
  • Catechin / analogs & derivatives
  • Catechin / therapeutic use
  • Cell Proliferation / drug effects
  • Disease Progression
  • Female
  • Flavonoids / administration & dosage
  • Flavonoids / therapeutic use*
  • Immunohistochemistry
  • JNK Mitogen-Activated Protein Kinases / metabolism
  • Lung / drug effects
  • Lung / metabolism
  • Lung / pathology
  • Lung Neoplasms / chemically induced
  • Lung Neoplasms / pathology
  • Lung Neoplasms / prevention & control*
  • Mice
  • Mice, Inbred Strains
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3 / metabolism
  • Nitrosamines / administration & dosage
  • Nitrosamines / toxicity
  • Phenols / administration & dosage
  • Phenols / therapeutic use*
  • Phosphorylation / drug effects
  • Polyphenols
  • Proliferating Cell Nuclear Antigen / analysis
  • Tea / chemistry*
  • Time Factors

Substances

  • Flavonoids
  • Nitrosamines
  • Phenols
  • Polyphenols
  • Proliferating Cell Nuclear Antigen
  • Tea
  • Caffeine
  • 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone
  • Catechin
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • polyphenon E